These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30700767)

  • 41. CanDrA: cancer-specific driver missense mutation annotation with optimized features.
    Mao Y; Chen H; Liang H; Meric-Bernstam F; Mills GB; Chen K
    PLoS One; 2013; 8(10):e77945. PubMed ID: 24205039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive assessment of computational algorithms in predicting cancer driver mutations.
    Chen H; Li J; Wang Y; Ng PK; Tsang YH; Shaw KR; Mills GB; Liang H
    Genome Biol; 2020 Feb; 21(1):43. PubMed ID: 32079540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identifying Epistasis in Cancer Genomes: A Delicate Affair.
    van de Haar J; Canisius S; Yu MK; Voest EE; Wessels LFA; Ideker T
    Cell; 2019 May; 177(6):1375-1383. PubMed ID: 31150618
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
    Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
    Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Evolutionary Approach for Identifying Driver Mutations in Colorectal Cancer.
    Foo J; Liu LL; Leder K; Riester M; Iwasa Y; Lengauer C; Michor F
    PLoS Comput Biol; 2015 Sep; 11(9):e1004350. PubMed ID: 26379039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
    Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
    Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binning somatic mutations based on biological knowledge for predicting survival: an application in renal cell carcinoma.
    Kim D; Li R; Dudek SM; Wallace JR; Ritchie MD
    Pac Symp Biocomput; 2015; ():96-107. PubMed ID: 25592572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of computational methods for predicting the effects of missense mutations in human cancers.
    Gnad F; Baucom A; Mukhyala K; Manning G; Zhang Z
    BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S7. PubMed ID: 23819521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic changes of driver genes' mutations across clinical stages in nine cancer types.
    Li X
    Cancer Med; 2016 Jul; 5(7):1556-65. PubMed ID: 26992457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A CATH domain functional family based approach to identify putative cancer driver genes and driver mutations.
    Ashford P; Pang CSM; Moya-García AA; Adeyelu T; Orengo CA
    Sci Rep; 2019 Jan; 9(1):263. PubMed ID: 30670742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring preferred amino acid mutations in cancer genes: Applications to identify potential drug targets.
    Anoosha P; Sakthivel R; Michael Gromiha M
    Biochim Biophys Acta; 2016 Feb; 1862(2):155-65. PubMed ID: 26581171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating the evaluation of cancer driver genes.
    Tokheim CJ; Papadopoulos N; Kinzler KW; Vogelstein B; Karchin R
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14330-14335. PubMed ID: 27911828
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computational approaches for the identification of cancer genes and pathways.
    Dimitrakopoulos CM; Beerenwinkel N
    Wiley Interdiscip Rev Syst Biol Med; 2017 Jan; 9(1):. PubMed ID: 27863091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer driver mutations: predictions and reality.
    Ostroverkhova D; Przytycka TM; Panchenko AR
    Trends Mol Med; 2023 Jul; 29(7):554-566. PubMed ID: 37076339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting the functional consequences of somatic missense mutations found in tumors.
    Carter H; Karchin R
    Methods Mol Biol; 2014; 1101():135-59. PubMed ID: 24233781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Current topics in mutations in the cancer genome].
    Iwaya T; Mimori K; Wakabayashi G
    Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):185-90. PubMed ID: 22582578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Shared and unique mutational gene co-occurrences in cancers.
    Liu J; Zhao D; Fan R
    Biochem Biophys Res Commun; 2015 Oct; 465(4):777-83. PubMed ID: 26315265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comprehensive characteristics of somatic mutations in the normal tissues of patients with cancer and existence of somatic mutant clones linked to cancer development.
    Oh JH; Sung CO
    J Med Genet; 2021 Jul; 58(7):433-441. PubMed ID: 32719100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Passenger Hotspot Mutations in Cancer.
    Hess JM; Bernards A; Kim J; Miller M; Taylor-Weiner A; Haradhvala NJ; Lawrence MS; Getz G
    Cancer Cell; 2019 Sep; 36(3):288-301.e14. PubMed ID: 31526759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.
    Raphael BJ; Vandin F
    J Comput Biol; 2015 Jun; 22(6):510-27. PubMed ID: 25785493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.